Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Capital Work in Progress

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹225 Cr₹137 Cr₹64 Cr₹130 Cr₹223 Cr

What is the latest Capital Work in Progress ratio of NATCO PHARMA ?

The latest Capital Work in Progress ratio of NATCO PHARMA is ₹225 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹225 Cr
Mar2024₹137 Cr
Mar2023₹64 Cr
Mar2022₹130 Cr
Mar2021₹223 Cr

How is Capital Work in Progress of NATCO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹225 Cr
64.17
Mar2024 ₹137 Cr
113.53
Mar2023 ₹64 Cr
-50.35
Mar2022 ₹130 Cr
-42.03
Mar2021 ₹223 Cr -

Compare Capital Work in Progress of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,402.6 Cr -3.4% -6.7% -26.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3.4%

-6.7%

-26.4%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses